| Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer V Karpisheh, A Nikkhoo, M Hojjat-Farsangi, A Namdar, G Azizi, ... Prostaglandins & other lipid mediators 144, 106338, 2019 | 116 | 2019 |
| Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies S Vakili-Samiani, AT Jalil, WK Abdelbasset, AV Yumashev, V Karpisheh, ... DNA repair 107, 103203, 2021 | 109 | 2021 |
| Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression F Hajizadeh, SM Ardebili, MB Moornani, A Masjedi, F Atyabi, M Kiani, ... European journal of pharmacology 882, 173235, 2020 | 66 | 2020 |
| The role of regulatory T cells in the pathogenesis and treatment of prostate cancer V Karpisheh, SM Mousavi, PN Sheykholeslami, M Fathi, MM Saray, ... Life sciences 284, 119132, 2021 | 57 | 2021 |
| The role of Th17 cells in the pathogenesis and treatment of breast cancer V Karpisheh, M Ahmadi, K Abbaszadeh-Goudarzi, ... Cancer Cell International 22 (1), 108, 2022 | 54 | 2022 |
| Codelivery of HIF-1α siRNA and dinaciclib by carboxylated graphene oxide-trimethyl chitosan-hyaluronate nanoparticles significantly suppresses cancer cell progression S Izadi, A Moslehi, H Kheiry, F Karoon Kiani, A Ahmadi, A Masjedi, ... Pharmaceutical Research 37, 1-20, 2020 | 48 | 2020 |
| & Jadidi-Niaragh, F.(2021). Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies S Vakili-Samiani, AT Jalil, WK Abdelbasset, AV Yumashev, V Karpisheh, ... DNA repair 103203, 0 | 48 | |
| Inhibition of HIF-1α/EP4 axis by hyaluronate-trimethyl chitosan-SPION nanoparticles markedly suppresses the growth and development of cancer cells V Karpisheh, JF Afjadi, MN Afjadi, MS Haeri, TSA Sough, SH Asl, ... International Journal of Biological Macromolecules 167, 1006-1019, 2021 | 42 | 2021 |
| T‐cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer M Fathi, I Pustokhina, SV Kuznetsov, M Khayrullin, M Hojjat‐Farsangi, ... IUBMB life 73 (5), 726-738, 2021 | 39 | 2021 |
| Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression N Joshi, F Hajizadeh, EA Dezfouli, AO Zekiy, MN Afjadi, SM Mousavi, ... Life sciences 275, 119369, 2021 | 36 | 2021 |
| EP4 receptor as a novel promising therapeutic target in colon cancer V Karpisheh, N Joshi, AO Zekiy, B Beyzai, M Hojjat-Farsangi, A Namdar, ... Pathology-Research and Practice 216 (12), 153247, 2020 | 36 | 2020 |
| Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro … AMS Khesht, V Karpisheh, PS Gilan, LA Melnikova, AO Zekiy, ... International journal of biological macromolecules 186, 849-863, 2021 | 33 | 2021 |
| Different T cell related immunological profiles in COVID-19 patients compared to healthy controls AMS Khesht, V Karpisheh, BQ Saeed, AO Zekiy, LM Yapanto, MN Afjadi, ... International immunopharmacology 97, 107828, 2021 | 31 | 2021 |
| Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells M Fathi, S Bahmanpour, A Barshidi, H Rasouli, FK Kiani, AMS Khesht, ... International immunopharmacology 101, 108288, 2021 | 27 | 2021 |
| The molecular biology and therapeutic potential of Nrf2 in leukemia A Khodakarami, S Adibfar, V Karpisheh, S Abolhasani, P Jalali, ... Cancer Cell International 22 (1), 241, 2022 | 23 | 2022 |
| Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art Z Hatami, ZS Hashemi, M Eftekhary, A Amiri, V Karpisheh, K Nasrollahi, ... Cancer cell international 23 (1), 157, 2023 | 20 | 2023 |
| Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan … AAH Feizi, S Vakili-Samiani, V Karpisheh, A Masjedi, S Izadi, S Adibfar, ... Journal of Drug Delivery Science and Technology 77, 103868, 2022 | 7 | 2022 |
| Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor … S Adibfar, A Masjedi, A Nazer, B Rashidi, V Karpisheh, S Izadi, ... Life sciences 309, 121008, 2022 | 6 | 2022 |
| Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide A Khodakarami, MA Kashani, A Nazer, AM Kheshti, B Rashidi, ... Cell Communication and Signaling 21 (1), 188, 2023 | 5 | 2023 |
| The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia S Abolhasani, SS Hejazian, V Karpisheh, A Khodakarami, H Mohammadi, ... IUBMB life 75 (3), 257-278, 2023 | 5 | 2023 |
Farhad Jadidi-NiaraghTabriz University of Medical SciencesGeverifieerd e-mailadres voor tbzmed.ac.ir